Curatis Aktie
| 12,55CHF | -0,85CHF | -6,34% |
WKN DE: A40BDL / ISIN: CH1330780979
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 0 | 0 | 0 | 0 | 7 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,00 | 0,99 |
Bilanz (in Mio. CHF) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 0 | 0 | 2 | 0 | 6 |
| Summe Anlagevermögen | 0 | 0 | 12 | 0 | 50 |
| Summe Aktiva | 0 | 0 | 14 | 0 | 56 |
Bilanz (in Mio. CHF) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 0 | 1 | 7 | 0 | 10 |
| Summe Eigenkapital | 0 | 0 | 7 | 0 | 46 |
| Summe Passiva | 0 | 0 | 14 | 0 | 56 |
Adresse
| Weierweg 7, 4410 Liestal | |
| Telefon | +41 (61) 927-87-77 |
| Internet | http://curatis.com |
Management
|
François Bersier
Chief Operating Officer |
|
Günter Graubach
Executive Director |
|
Kirsty Crame
Chief Medical Officer |
|
Marian Borovsky
Chairman |
|
Patrick Ramsauer
Chief Financial Officer |
|
Roland Rutschmann
Chief Executive Officer & Executive Director |
|
Silvio Inderbitzin
Non-Executive Director |
|
Timm Trenktrog
Head-Chemistry, Manufacturing & Controls |